{"id":"W4200143795","doi":"10.1016/j.eclinm.2021.101240","title":"Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes","year":2021,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Daiichi-Sankyo; Novo Nordisk; Intarcia Therapeutics; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Renal function; Kidney disease; Internal medicine; Proteinuria; Type 2 diabetes; Placebo; Creatinine; Diabetes mellitus; Kidney; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005097344,0.0003724578,0.0008532879,0.0002703067,0.0001354468,0.0005307515,0.0003947332,0.0004208171,0.001837012],"category_scores_gemma":[0.005019038,0.0001388614,0.00169972,0.0003145141,0.0002379965,0.0003606366,0.0004013151,0.001056789,0.0001161847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000322773,"about_ca_system_score_gemma":0.0007505396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000962893,"about_ca_topic_score_gemma":0.001448744,"domain_scores_codex":[0.9985822,0.0008639169,0.00008388831,0.0001559492,0.0002151161,0.00009887674],"domain_scores_gemma":[0.9969906,0.001532299,0.0007868899,0.0002168211,0.0001526514,0.0003207606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4599366,0.00381458,0.4049575,0.001565843,0.01374182,0.0001431558,0.00009566766,0.003149509,0.001463756,0.0002972657,0.002786941,0.1080474],"study_design_scores_gemma":[0.03497591,0.03049543,0.9116477,0.0002617064,0.009531938,0.0002664526,0.00004691023,0.007849688,0.001554685,0.0006706728,0.002652932,0.00004599799],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916372,0.004865268,0.000550656,0.000335003,0.00007258065,0.0001221038,0.0009654144,0.00002589686,0.001425915],"genre_scores_gemma":[0.9976192,0.0005639531,0.000392771,0.0001286941,0.00006577447,0.0001137114,0.0007341429,0.000003930453,0.0003778682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005097344,"threshold_uncertainty_score":0.02695763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02353991349163101,"score_gpt":0.3644451173646002,"score_spread":0.3409052038729692,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}